Site identification and selection: current practices within the trial managers network and NIHR chief investigators.

Dawn Coleby; Diane Whitham; Lelia Duley

doi:10.1186/1745-6215-16-S2-P175

Site identification and selection: current practices within the trial managers network and NIHR chief investigators.

Dawn Coleby, Diane Whitham, Lelia Duley

University of Nottingham

Research output: Contribution to conference › Poster › peer-review

Abstract

Selecting sites is an important part of a clinical trial. Selection of poor sites can lead to reduced recruitment and lower quality of data. Currently there are no tools available to assess either suitability of a potential site, or factors that could be addressed to improve suitability.

In order to develop a ‘site selection tool’ to improve site selection, we surveyed Trial Managers and Chief Investigators to ask about their current practice for choosing sites in their trial. The aim was to identify ‘key performance factors’.

Original language	English
Pages	175
Number of pages	1
DOIs	https://doi.org/10.1186/1745-6215-16-S2-P175
Publication status	Published - Nov 2015
Externally published	Yes

Access to Document

10.1186/1745-6215-16-S2-P175

Cite this

@conference{5809ee8c4f60444288f4ebef1e272ac1,

title = "Site identification and selection: current practices within the trial managers network and NIHR chief investigators.",

abstract = "Selecting sites is an important part of a clinical trial. Selection of poor sites can lead to reduced recruitment and lower quality of data. Currently there are no tools available to assess either suitability of a potential site, or factors that could be addressed to improve suitability.In order to develop a {\textquoteleft}site selection tool{\textquoteright} to improve site selection, we surveyed Trial Managers and Chief Investigators to ask about their current practice for choosing sites in their trial. The aim was to identify {\textquoteleft}key performance factors{\textquoteright}.",

author = "Dawn Coleby and Diane Whitham and Lelia Duley",

year = "2015",

month = nov,

doi = "10.1186/1745-6215-16-S2-P175",

language = "English",

pages = "175",

}

TY - CONF

T1 - Site identification and selection

T2 - current practices within the trial managers network and NIHR chief investigators.

AU - Coleby, Dawn

AU - Whitham, Diane

AU - Duley, Lelia

PY - 2015/11

Y1 - 2015/11

N2 - Selecting sites is an important part of a clinical trial. Selection of poor sites can lead to reduced recruitment and lower quality of data. Currently there are no tools available to assess either suitability of a potential site, or factors that could be addressed to improve suitability.In order to develop a ‘site selection tool’ to improve site selection, we surveyed Trial Managers and Chief Investigators to ask about their current practice for choosing sites in their trial. The aim was to identify ‘key performance factors’.

AB - Selecting sites is an important part of a clinical trial. Selection of poor sites can lead to reduced recruitment and lower quality of data. Currently there are no tools available to assess either suitability of a potential site, or factors that could be addressed to improve suitability.In order to develop a ‘site selection tool’ to improve site selection, we surveyed Trial Managers and Chief Investigators to ask about their current practice for choosing sites in their trial. The aim was to identify ‘key performance factors’.

U2 - 10.1186/1745-6215-16-S2-P175

DO - 10.1186/1745-6215-16-S2-P175

M3 - Poster

SP - 175

ER -

Site identification and selection: current practices within the trial managers network and NIHR chief investigators.

Abstract

Access to Document

Fingerprint

Cite this